Tag: mit

3 Conditions that Must be Met to Make Interoperability a Reality

3 Conditions that Must be Met to Make Interoperability a Reality

MedCity News

The term “interoperability” holds different meanings for different people. While we all would agree that the primary goal of interoperability is to make sharing data easier in order to improve outcomes and lower costs, there are varying perceptions about what that looks like. FHIR has been great at giving us a common set of protocols and standards to work from, but how we connect and how data actually gets shared are still open challenges.
In a truly interoperable healthcare ecosystem, I strongly believe data wouldn’t need to be requested, aggregated, and validated each time it’s needed. And it wouldn’t be limited to specific…

Continue Reading
Ingestible Sensor Reveals Gastric Motility

Ingestible Sensor Reveals Gastric Motility

Medgadget

Researchers at MIT have developed an ingestible sensor that can reveal gastrointestinal motility issues, such as gastroparesis and gastroesophageal reflux disease. The technology is intended for use as an easy at-home method to diagnose such issues, which typically require more invasive and inconvenient procedures, such as endoscopy or X-ray imaging. This new technology is based on the concept that a magnetic field produced by an electromagnetic coil becomes weaker the further away you move from the coil. This change in field signal is predictable, allowing researchers to calculate the distance accurately by measuring the magnetic field. The ingestible sensor measures […]…

Continue Reading
Automated Mass Spec Technique to Detect Antidepressants

Automated Mass Spec Technique to Detect Antidepressants

Medgadget

Scientists at Brown University have designed an automated liquid chromatography tandem mass spectrometry (LC-MS/MS) system that allows clinicians to rapidly and easily process patient samples to determine levels of antidepressant drugs in the body. Getting the correct dose of antidepressant drugs into the bloodstream is important to ensure efficacy and avoid side-effects. However, current assays to measure the levels of such drugs in the blood are cumbersome, require large blood samples, and involve multiple time-consuming steps, limiting their use by clinicians. This new system requires very small sample volumes, and employs a robot liquid handling system that is commonly found […]…

Continue Reading
Health equity hindered by SDOH coding roadblocks

Health equity hindered by SDOH coding roadblocks

Healthcare IT news

A new American Health Information Management Association study aimed at finding a better understanding of the operational realities of how social determinants of health data is used in real-world healthcare scenarios, finding a lack of standardization, insufficient training and limited cross-sector use.WHY IT MATTERS
The study, conducted by NORC at the University of Chicago, surveyed more than 2,600 AHIMA members and nonmembers from a pool of 41,000 potential respondents between August 24 and September 9, 2022.
Respondents included coding professionals; managers, directors and vice presidents of health information management; HIM team members and executives. 
SDOH data can offer additional insights to help enrich clinical decision-making…

Continue Reading
MD Anderson’s Tech Puts Replay on Fast Path to Clinic With TCR NK Cell Therapies

MD Anderson’s Tech Puts Replay on Fast Path to Clinic With TCR NK Cell Therapies

MedCity News

A slew of biotech companies are pursuing research that could overcome limitations of current cell therapies. Startup creator Replay has a new subsidiary pushing toward the front of the pack with a therapeutic candidate on track to start its first human test this summer—about one year after Replay emerged from stealth. It owes this rapid progress to a cell therapy pioneer’s technology that has already been de-risked by a big pharmaceutical company.
Replay calls itself a genome writing company. With operations split between San Diego and London, the private equity-backed business launched last July with $55 million and a suite of technologies…

Continue Reading
Caraway, Ash Wellness Launch Partnership to Combat Rise in STIs on College Campuses

Caraway, Ash Wellness Launch Partnership to Combat Rise in STIs on College Campuses

MedCity News

In order to catch the attention of reporters, companies often look for creative news hooks to tie their announcements to. Two companies have decided to use Valentine’s Day to forward their message of sexually transmitted infection prevention. How romantic!
Digital health startup Caraway Health is teaming up with at-home testing company Ash Wellness to provide STI kits for those aged 18 to 27, the companies announced Tuesday. New York City-based Caraway provides mental, physical and reproductive health services for Gen-Z populations, with a particular focus on women and people assigned female at birth. It offers an app that enables users to access its…

Continue Reading
Adverse Survival Signal Leads G1 to Stop Pivotal Test in Colorectal Cancer

Adverse Survival Signal Leads G1 to Stop Pivotal Test in Colorectal Cancer

MedCity News

G1 Therapeutics’ approach to cancer does not kill tumors. Instead, the biotech’s drug, trilaciclib, protects bone marrow from the damaging effects of chemotherapy, reducing the duration and severity of the problems that can limit the use of this cancer treatment. Since trilaciclib’s initial approval insmall cell lung cancer, G1 has pursued more clinical trials that could support expanding the drug to other cancers. Colorectal cancer will no longer be one of them.
On Monday, G1 reported preliminary data showing that the placebo group outperformed the trilaciclib arm in helping patients live longer. G1 said it has decided to stop the colorectal cancer…

Continue Reading
2021 Tech Forum: Integrating SDOH Data Into Clinical Systems & Connecting with Human Services

2021 Tech Forum: Integrating SDOH Data Into Clinical Systems & Connecting with Human Services

Office of the National Coordinator for Health IT

September 10, 2021Providers are increasingly capturing SDOH data from patients as part of a clinical encounter and using this data to help inform clinical care delivery and to support social care referrals in the community. Existing and emerging health IT standards and codes sets specific to SDOH enable this data to be integrated into a care record and exchanged to support referrals aligned with an individuals’ social need(s). This session will outline technical workflows and use cases for integrating SDOH data into an EHR and as part of a shared care plan and will describe the applicable standards and codes sets…

Continue Reading
2022 Tech Forum: Developing Clinical Decision Support with SDOH Data for Improved Patient Outcomes

2022 Tech Forum: Developing Clinical Decision Support with SDOH Data for Improved Patient Outcomes

Office of the National Coordinator for Health IT

September 16, 2022This session will identify next steps to advance electronic clinical decision support (CDS) focused on social determinants of health (SDOH). We are interested in exploring the different stages of guideline development to determine an outcome of successful CDS that incorporates SDOH. JaWanna Henry, MPH, ONC (Moderator) Alison Kemp, MPH, ONC (Moderator) Rose Almonte, MITREMike Gillam, MD, FACEP, HealthLab Kristen Miller, DrPH, MSPH, MSL, CPPS, MedStar Health Research Institute Douglas E. Peterson, DMD, PhD, FDS RCSEd, FASCO, UConn Health Mona Saraiya, MD, MPH, Centers for Disease Control and Prevention Scott T. Tagawa, MD, MS, FACP, Weill Cornell Medicine Emily C….

Continue Reading
Antibacterial Smart Sutures Visible in CT Scans

Antibacterial Smart Sutures Visible in CT Scans

Medgadget

Researchers at RMIT University in Australia have developed ‘smart stitches’ that can fight bacteria and reveal the location of the sutured area in CT scans. The sutures have been developed to reduce the chances of surgical site infections and also make life a little easier for clinicians, as the material shows up in CT scans, allowing for identification of the location of the sutures in the body and quick assessment if they are performing as required. In particular, the researchers envisage the sutures as a replacement for vaginal meshes that are used to treat prolapses, for which surgical site infection […]…

Continue Reading